超加工食品和代谢功能障碍:对饮食加工,行为驱动因素和慢性疾病风险的叙述性审查
Tyler J Godsey1, Travis Eden1, Sam R Emerson1
1Department of Nutritional Sciences, Oklahoma State University, Stillwater, OK 74078, USA.
Metabolites
|December 24, 2025
概括
超加工食品 (UPF) 与饮食质量差和代谢问题有关. 减少UPF消耗可能会改善能量平衡,炎症和肠道健康,但需要更多的干预研究.
科学领域:
- 营养科学 营养科学
- 公共卫生 公共卫生
- 代谢健康 代谢健康
背景情况:
- 超加工食品 (UPF) 在现代饮食中越来越普遍.
- 他们的起与全球肥胖和慢性疾病的增加并行.
研究的目的:
- 审查饮食加工和UPF消费对代谢健康的影响.
- 综合关于UPF对饮食质量,能量平衡和生物通路的影响的证据.
主要方法:
- 对同行评审的文章和报告进行有针对性的文献搜索.
- 专注于UPF定义 (NOVA分类),消费,驱动因素,组成和代谢联系.
- 强调了最近关于UPF和代谢功能障碍的人类和动物研究.
主要成果:
- 高UPF摄入量与更低的饮食质量,更高的能量密度和更快的进食率相关.
- UPFs有助于过度的能量摄入,脂肪,炎症和肠道微生物组的改变.
- 证据主要是观察性的;因果干预试验有限.
结论:
- 由于营养成分和加工效应,UPF可能会增加慢性疾病的风险.
- 需要进一步的研究,特别是干预研究,以确认因果关系并指导公共卫生战略.
- 减少UPF消费可能会对能量平衡,炎症和肠道健康产生积极影响.
相关概念视频
Overview of Carbohydrate Metabolism
3.2K
Carbohydrate metabolism is a fundamental biochemical process that ensures a constant supply of energy to living cells. The most important carbohydrate is glucose, which can be broken down via glycolysis to enter into the Krebs cycle and eventually lead to the production of ATP through oxidative phosphorylation.
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
3.2K
Obesity
1.1K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.1K
Coronary Artery Disease I: Introduction
846
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
846
Overview of Lipid Metabolism
4.7K
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
4.7K
Overview of Protein Metabolism
3.5K
Proteins are broken down into amino acids during digestion. Unlike fats and carbohydrates, which are stored for later use, proteins are not. Instead, amino acids are either used to produce ATP through oxidation or contribute to the creation of new proteins for the growth and repair of the body. Any surplus amino acids from the diet are converted into glucose or triglycerides rather than excreted.
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
3.5K
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
153
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
153


